Endocrine Testing (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others) Market - Forecasts to 2019

DUBLIN, April 30, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/k8kpmg/endocrine_testing) has announced the addition of the "Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests.

The market accounts for a wide range of conventional as well as rapid diagnostic kits used for detecting deficiency (hyposecretion) or excess (hypersecretion) secretions of these hormones. The diagnostic technologies segment further describes the technological platforms used in the analysis of the specimen test sample (blood, urine, etc) and is further categorized into five major technologies, tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor and clinical chemistry technologies. The end user segment elucidates the endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician's offices.

On the basis of geography, the market is classified into North America, Europe, Asia-Pacific, Africa, Latin America and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the endocrine testing market and future opportunities are provided in the report. A PESTLE analysis has also been considered while estimating the market for individual geographies in order to provide current as well as future status. Several other analytical perspectives such as Porter's Five Forces Analysis, market share analysis and market attractiveness have been described in the report in order to give a thorough analysis of the market. Also, a list of recommendations for existing as well as new entrants has also been discussed in the study which would help in decision making.

Key Topics Covered:

Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Endocrine Testing Market, by Test
Chapter 5 Endocrine Testing Market, by Diagnostic Technologies
Chapter 6 Endocrine Testing Market, by End Users
Chapter 7 Endocrine Testing Market, by Geography
Chapter 8 Competitive Landscape
Chapter 9 Recommendations
Chapter 10 Company Profiles

Companies Mentioned:

• Abbott Laboratories
• AB SCIEX LLC
• Agilent Technologies
• Biomedical Diagnostics
• bioMerieux
• Bio-Rad Laboratories, Inc.
• DiaSorin S.p.A
• F. Hoffmann-La Roche Ltd.
• Laboratory Corporation of America Holdings (LabCorp)
• Ortho Clinical Diagnostics
• Quest Diagnostics
• Siemens Healthcare
• Sysmex Corporation
• Thermo Fisher Scientific

For more information visit http://www.researchandmarkets.com/research/k8kpmg/endocrine_testing

Media Contact: Laura Wood, +353-1-481-1716, [email protected]

SOURCE Research and Markets